Biomarker carries out the main business of science and technology services, medical gene detection and biological cloud platform.
To innovate biotechnology
To Serve the society
To Benefit people
To create innovative biotechnology center and establish a symbolic enterprise in bio-industry
Biomarker in numbers
Institutions of scientific research institutions, independent laboratories, pharmaceutical companies et al .
The cumulative number of articles published in ten years.
Accumulated impact factors for 10 years.
Multi-level, multi-selective and high-throughput sequencing platform/international leading, specialized and automated molecular experimental platform/medical laboratory platform meeting clinical laboratory standards/safe, reliable, friendly and easy-to-use bioinformatics analysis platform
- Nanopore PromethION, MinION, GridION X5
- Illumina Hiseq 4000, Hiseq 2500, Miseq
- PacBio Sequel, PacBio RS Ⅱ, PacBio Sequel Ⅱ
- BioNano Irys system.
- DA proton
- Waters UPLC I class PLUS & Xevo G2-XS QTOF